HR 6479, the Puerto Rico Affordable Care Act of 2025, would extend key provisions of the Affordable Care Act to Puerto Rico. Specifically, it requires Puerto Rico to establish a health insurance marketplace (Exchange) one year after enactment, applies federal health insurance market reforms (like banning lifetime limits) to coverage sold there, and treats Puerto Rico like a state for federal premium tax credits. This means Puerto Rico residents would gain access to the same health insurance marketplaces, consumer protections, and federal subsidies for low-income residents as those in states. The bill directly affects all Puerto Rico residents seeking health insurance coverage by aligning their access with the ACA framework.
HR 5813, the Women’s Health and Cancer Rights Modernization Act of 2025, requires health insurance plans to cover all medically necessary breast or chest wall reconstruction services following breast cancer treatment, including mastectomy or breast-conserving surgery. It mandates coverage for every reconstruction method (like implants, tissue flaps, or future recognized techniques), symmetrical surgery for the other breast, custom prostheses, and treatment of complications like lymphedema. Health plans must ensure at least one in-network provider for each reconstruction type, provide annual written notices to patients about this coverage, and cannot deny coverage or penalize providers for following these requirements. This applies to group and individual health insurance plans, with no effect on stricter state laws requiring broader coverage.
The RESTORE Act (S 1882) aims to improve reproductive health care by expanding access to restorative reproductive medicine, which focuses on diagnosing and treating underlying causes of infertility rather than solely using assisted reproductive technologies. The bill requires the Department of Health and Human Services to conduct regular literature reviews on standard care for infertility and reproductive health conditions, and to modernize medical coding to better classify and reimburse restorative treatments like laparoscopic excision for endometriosis. It also expands Title X funding eligibility for restorative medicine providers, advances education on fertility awareness-based methods, and directs the National Survey of Family Growth to collect data on reproductive health conditions. These changes primarily affect women and men with conditions like endometriosis, polycystic ovary syndrome, and uterine fibroids, as well as healthcare providers and health insurance plans. The legislation seeks to address gaps in diagnosis, treatment, and coverage for reproductive health conditions that impact 15-16% of couples experiencing infertility.
The Healthcare Freedom Act of 2025 would rename health savings accounts as "health freedom accounts" and make them available to all individuals, removing the previous requirement of having a high-deductible health plan. It increases the annual contribution limit to $12,000 (or $24,000 for joint returns) and expands eligible expenses to include direct primary care and health care sharing ministries. Employers could contribute to these accounts for new hires starting five years after enactment, with a transition rule for existing accounts. The bill would directly affect individuals using these accounts and employers who choose to participate in the new system.
HR 211, the Equal Access to Contraception for Veterans Act, eliminates out-of-pocket costs for specific contraceptives for veterans using VA healthcare. It amends Section 1722A of Title 38 to prohibit the VA from charging veterans copayments for contraceptive items that must be covered without cost-sharing under federal law (as required by Section 2713(a)(4) of the Public Health Service Act). This means veterans will not pay any amount for contraceptives covered by the federal mandate, such as birth control pills or IUDs, when obtained through the VA system. The bill directly affects veterans enrolled in VA healthcare seeking contraceptive services, ensuring no additional costs beyond what is already mandated for these items.
The Fair Prescription Drug Prices for Americans Act would cap the U.S. list price for prescription drugs and biological products at the average price in Canada, France, Germany, Italy, Japan, and the United Kingdom. Drug manufacturers must annually report U.S. and international prices to the Health and Human Services Secretary, who calculates the six-country average. If a U.S. price exceeds this average, manufacturers face a civil penalty of 10 times the price difference per unit sold. The bill directly targets drug pricing practices without altering drug approval processes or insurance coverage.
This bill establishes 12-month continuous enrollment for Medicaid and CHIP (Children's Health Insurance Program) beneficiaries, meaning individuals enrolled in these programs will not need to renew coverage annually. It removes the previous age limit of 19 for Medicaid coverage and updates language to refer to "individuals" instead of "children" in enrollment rules. The changes directly affect current and future Medicaid and CHIP recipients who would otherwise face annual renewal requirements. The policy takes effect one year after the bill's enactment, providing more stable health coverage for low-income families and children.
This bill amends IRS rules to clarify that contractors primarily providing services to educational organizations (like schools) are treated similarly to employees for health coverage purposes. Specifically, it changes Section 4980H of the tax code so that these contractors count toward full-time employee thresholds when determining if an educational organization must offer health insurance. This directly affects schools and their operations/logistics contractors, requiring schools to include these contractors when assessing health coverage obligations under employer mandates. The change applies to months beginning after the bill's enactment date.
HR 2553, the Capping Prescription Costs Act of 2025, limits out-of-pocket costs for prescription drugs under health insurance. It sets a $2,000 annual cap per individual or $4,000 per family for covered prescriptions starting in 2026, with annual adjustments based on the medical care CPI. The bill applies directly to people with employer-sponsored group health plans, individual health insurance plans, and plans covered under the Affordable Care Act. It requires insurers and plan sponsors to ensure cost-sharing for prescriptions does not exceed these limits, effective for plan years beginning January 1, 2026.
This bill requires most health insurance plans to cover HIV prevention services - including PrEP and PEP drugs, related lab tests, counseling, and monitoring - without cost-sharing (like copays or deductibles) or prior approval. It applies to private insurance, Medicare, Medicaid/CHIP, and federal employee health plans, directly affecting people who use HIV prevention medications. Key provisions mandate 100% coverage for FDA-approved HIV prevention drugs, eliminate cost-sharing for these services, and prohibit insurers from requiring preauthorization for them. The bill defines covered services to include all necessary components of HIV prevention care as outlined in current public health guidelines.
